The Chinese pharma industry experienced a 25% drop in new job postings in Q3 2023 compared with the previous quarter, with the highest share accounted for by AstraZeneca with 894 job postings according to GlobalData’s analysis of pharma company job postings. GlobalData’s Pharma: Hiring Trends & Signals Q3 2023 report reveals comprehensive insights into hiring patterns, job roles, required skills, geographical trends, and key themes within the pharmaceuticals industry, facilitating anticipation of future workforce needs. Buy the report here.
Notably, Healthcare Practitioners and Technical Occupations jobs accounted for a 19% share of the Chinese pharma industry new job postings in Q3 2023, down by 9% over the prior quarter.
Healthcare Practitioners and Technical Occupations drive pharma industry hiring activity
Of the industry's total hiring activity, the highest number of new job postings were for Healthcare Practitioners and Technical Occupations, which accounted for 19% of the total new job postings in Q3 2023 and were up by 10% year-on-year. Second highest were Management Occupations, which accounted for 10% and drop by 47% year-on-year, and third highest were Sales and Related Occupations, which were 79% of the new job postings and 62% lower year-on-year.
See Also:
Top five companies in pharma industry accounted for 55% of hiring activity
The highest number of jobs were posted by AstraZeneca with 894, followed by Pfizer with 479, while the highest increase was at Sanofi at 28%.
For further understanding of GlobalData's Pharma: Hiring Trends & Signals Q3 2023, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.